Axogen (AXGN) EPS (Weighted Average and Diluted) (2019 - 2025)
Axogen has reported EPS (Weighted Average and Diluted) over the past 9 years, most recently at -$0.28 for Q4 2025.
- Quarterly results put EPS (Weighted Average and Diluted) at -$0.28 for Q4 2025, down 2900.0% from a year ago — trailing twelve months through Dec 2025 was -$0.34 (down 54.55% YoY), and the annual figure for FY2025 was -$0.34, down 47.83%.
- EPS (Weighted Average and Diluted) for Q4 2025 was -$0.28 at Axogen, down from $0.01 in the prior quarter.
- Over the last five years, EPS (Weighted Average and Diluted) for AXGN hit a ceiling of $0.01 in Q2 2025 and a floor of -$0.28 in Q4 2025.
- Median EPS (Weighted Average and Diluted) over the past 5 years was -$0.12 (2021), compared with a mean of -$0.12.
- Peak annual rise in EPS (Weighted Average and Diluted) hit 125.0% in 2025, while the deepest fall reached 2900.0% in 2025.
- Axogen's EPS (Weighted Average and Diluted) stood at -$0.12 in 2021, then fell by 8.33% to -$0.13 in 2022, then surged by 30.77% to -$0.09 in 2023, then skyrocketed by 111.11% to $0.01 in 2024, then crashed by 2900.0% to -$0.28 in 2025.
- The last three reported values for EPS (Weighted Average and Diluted) were -$0.28 (Q4 2025), $0.01 (Q3 2025), and $0.01 (Q2 2025) per Business Quant data.